As of 2025-09-08, the Fair Value of Evofem Biosciences Inc (EVFM) is -22.07 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.48 USD, the upside of Evofem Biosciences Inc is -4,715.82%.
With the market price of 0.48 USD and our fair value calculation, Evofem Biosciences Inc (EVFM) is not a good investment. Investing in EVFM stocks now will result in a potential loss of 4,715.82%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -205.19 | -76.70 | 52.98 | -8.86 | -59.44 | |
| YoY growth | -44.19% | 62.62% | 169.07% | -116.72% | 17.70% | |
| Market Cap (mil) | 1.19 |
| P/E | |
| Forward P/E |
| EPS | -1.25 |
| Avg earnings growth rate | 17.70% |
| TTM earnings | -3.10 |